340B provider advocates and attorneys warned this week that a new Trump administration proposed rule overhauling the federal grant process [...] …
General
Switzerland-based Novartis this week began requiring all 340B covered entities to submit pharmacy and medical claims data on all dispenses, [...] …
Please Login or Become a Paid Subscriber to View this Content
Philip Perry, a longtime pharmaceutical industry attorney who has represented PhRMA and drug manufacturers in major 340B litigation, officially retired [...] …
Please Login or Become a Paid Subscriber to View this Content
A Florida hospital recently sued Eli Lilly, alleging the pharmaceutical giant unlawfully cut off 340B pricing after the hospital refused [...] …
Please Login or Become a Paid Subscriber to View this Content
A bipartisan U.S. House bill that would pause drug manufacturer 340B rebates, establish a new patient definition and create contract [...] …
Please Login or Become a Paid Subscriber to View this Content
AHA recently announced that it has selected the head of a Massachusetts hospital trade group to take over as its [...] …
Please Login or Become a Paid Subscriber to View this Content
AbbVie recently announced 340B contract pharmacy restrictions for its new federally approved drug used to treat Blastic plasmacytoid dendritic cell [...] …
Please Login or Become a Paid Subscriber to View this Content
The U.S. House Ways and Means Committee approved legislation along party lines Wednesday that would require certain nonprofit hospitals to [...] …
Please Login or Become a Paid Subscriber to View this Content
Seventy-two bipartisan U.S. House members urged federal health officials in a Wednesday letter to take “immediate action” against drugmaker Eli [...] …
Please Login or Become a Paid Subscriber to View this Content
A Colorado congresswoman, who has played a key role in shaping health and 340B policy on Capitol Hill for nearly [...] …